Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adults Clinical, Intravenous, Pharmacokinetic/SafetyANAD StaffJune 10, 2024
Safety and Metabolism of Long-Term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Healthy Overweight Adults Clinical, Pharmacokinetic/SafetyANAD StaffJuly 5, 2019
A Randomized Placebo-Controlled Clinical Trial of Nicotinamide Riboside in Obese Men: Safety, Insulin-Sensitivity, and Lipid-Mobilizing Effects Clinical, Pharmacokinetic/Safety, Liver Health, Metabolic HealthANAD StaffJuly 10, 2018
Chronic Nicotinamide Riboside Supplementation is Well-Tolerated and Elevates NAD+ in Healthy Middle-Aged and Older Adults Clinical, Pharmacokinetic/SafetyANAD StaffMarch 29, 2018
An Open-Label, Non-Randomized Study of the Pharmacokinetics of the Nutritional Supplement Nicotinamide Riboside (NR) and Its Effects on Blood NAD+ Levels in Healthy Volunteers Clinical, Pharmacokinetic/SafetyANAD StaffDecember 6, 2017
Nicotinamide Riboside is Uniquely and Orally Bioavailable in Mice and Humans Clinical, Pharmacokinetic/SafetyANAD StaffOctober 10, 2016
